In a 11-min video, five experts in addiction explain why KT-110 is a game changer and why it is a hope for millions of AUD patients. Henri-Jean Aubin is Professor of Psychiatry and Addictology at Hôpital Pitié-Salpétrière in Paris,
Kinnov Therapeutics was present at the 37th ECNP Congress
Kinnov Therapeutics was present at the 37th ECNP congress https://www.ecnp.eu/congress2024/ECNPcongress, in Milan 21-24 Sep, 2024. Within the scope of ECNP’s New Medications Symposium, Prof Henri-Jean Aubin and Julien Guiraud were invited to present results of phase 2 clinical trials. The